跳至主要内容
临床试验/NCT06932666
NCT06932666已完成不适用

Why Calories Are Not the Same - a Gut Explanation

University of Copenhagen1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年5月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Total fecal energy excretion (between high- and low-methane producers)

研究概览

简要总结

The aim of this study is to understand how the gut microbiome influences how much dietary energy humans excrete via feces. This study is based on the hypothesis that levels of methane in exhaled breath represent two different gut microbiome community structures, and therefore influence fecal energy excretion differently. Moreover, this study is assessed in the context of two different diets, both isocaloric and equal in macronutrient composition, but differing in contents of fiber, resistant starch, and large particles; which are hypothesized to impact the gut microbiome differently.

详细描述

The trial is a cross-over trial including two controlled isocaloric dietary interventions of three days duration. The two diets are isocaloric but with different contents of fiber, resistant starch, and food particle sizes. Each intervention is separated by a wash-out period of at least 10 days where participants adhere to their habitual diet. The trial includes a total of five visits (one screening visit and four regular visits).

Before the trial, participants undergo a screening period of 4 days. During the 4-day screening period, participants measure the levels of methane in their exhaled breath. Based on median breath methane levels, participants are allocated to one of the two arms: (HMP: high methane producers; LMP: low methane producers). Enrollment in the intervention trial will be conducted so there are similar numbers of participants in both arms.

At the beginning and at the end of each 3-day intervention period, participants consume a blue muffin, containing a royal blue dye that changes the stool color. The appearance of the color in stool following the first muffin will mark the beginning of the stool collection period, which will continue until the stool color change is no longer noticeable following consumption of the second muffin. Therefore, the duration of the stool collection period, which is estimated to be on average 3 days, will ultimately depend on the participants' passage time of food (i.e., intestinal transit time).

During the screening period, participants are asked to:

  • measure their methane and hydrogen levels in exhaled breath using a portable device
  • report defecation patterns (including stool frequency and Bristol Stool Scale)

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •18-65 years old
  • •BMI:18.5-29.9 kg/m2
  • •Self-reported regular defecations defined as at least every second day
  • •Willing to collect urine and stool samples at home and able to temporarily store them in their own freezer in a provided container
  • •Willing to exclusively eat the food provided
  • •Owning a smartphone (iOS 11.0 and onwards, or Android 5.0 and onwards) with access to the internet
  • •Speak and understand Danish or English

排除标准

  • •Current pregnancy or lactation
  • •Following a specific dietary program or diet (e.g., vegetarian, vegan, gluten-free) or unable to consume the food provided
  • •Diagnosis of small intestinal bacterial overgrowth (SIBO), inflammatory bowel diseases (IBD), gastrointestinal obstruction, or ischemic colitis
  • •Diagnosed chronic constipation
  • •Regular use of diarrhea inhibitors or laxatives
  • •Any chronic disease that can affect the outcomes of the study
  • •Use of medications potentially altering gastric pH (proton pump inhibitors, histamine receptor antagonists, antacids)
  • •Use of medications potentially altering the gastro-intestinal motility (prokinetics, antiemetic agents, anticholinergic agents, narcotic analgesics, nonsteroidal anti-inflammatory drugs, peroral glucocorticoids, and GLP-1 related medications such as semaglutide and liraglutide)
  • •Use of antibiotics, or any medication that can affect any outcomes of the study, within the previous three months
  • •Concurrent participation in another trial
  • •Any condition that makes the project responsible and/or the clinical responsible doubt the feasibility of the volunteer's participation

研究组 & 干预措施

High-methane producers

Experimental

Individuals exhaling high levels of methane (median exhaled methane >= 5 ppm), as measured 3-times daily during the screening period.

干预措施: Diet A group (Other)

High-methane producers

Experimental

Individuals exhaling high levels of methane (median exhaled methane >= 5 ppm), as measured 3-times daily during the screening period.

干预措施: Diet B group (Other)

Low-methane producers

Experimental

Individuals exhaling low levels of methane (median exhaled methane < 5 ppm), as measured 3-times daily during the screening period.

干预措施: Diet A group (Other)

Low-methane producers

Experimental

Individuals exhaling low levels of methane (median exhaled methane < 5 ppm), as measured 3-times daily during the screening period.

干预措施: Diet B group (Other)

结局指标

主要结局

Total fecal energy excretion (between high- and low-methane producers)

时间窗: During each stool collection period (following each 3-day intervention period)

Differences in total fecal energy excretion, determined as total kilocalories excreted via feces, between low and high methane producers following intake of the two controlled, isocaloric diets.

次要结局

  • Fecal host DNA concentration(During each 3-day intervention period and its following stool collection period)
  • Fecal short-chain fatty acids(During each 3-day intervention period and its following stool collection period)
  • Gut microbiome composition (16S)(During each 3-day intervention period and its following stool collection period)
  • Fecal microbial load(During each 3-day intervention period and its following stool collection period)
  • Whole-gut transit time(During each 3-day intervention period and its following stool collection period)
  • Stool consistency(During each 3-day intervention period and its following stool collection period)
  • Stool frequency(During each 3-day intervention period and its following stool collection period)
  • Stool moisture(During each 3-day intervention period and its following stool collection period)
  • Fecal pH(During each 3-day intervention period and its following stool collection period)
  • Total fecal energy excretion (between diet A and diet B)(During each stool collection period (following each 3-day intervention period))
  • Fecal energy density(During each 3-day intervention period and its following stool collection period)
  • Breath hydrogen and methane levels(During each 3-day intervention period and its following stool collection period)
  • Gut microbiome composition and functions (shotgun sequencing)(During each 3-day intervention period and its following stool collection period)
  • Total fecal energy excretion (between diet A and diet B)(During each stool collection period (following each 3-day intervention period))
  • Fecal energy density(During each 3-day intervention period and its following stool collection period)
  • Fecal microbial load(During each 3-day intervention period and its following stool collection period)
  • Total fecal weight excreted(During each 3-day intervention period and its following stool collection period)
  • Whole-gut transit time(During each 3-day intervention period and its following stool collection period)
  • Breath hydrogen and methane levels(During each 3-day intervention period and its following stool collection period)
  • Stool frequency(During each 3-day intervention period and its following stool collection period)
  • Stool consistency(During each 3-day intervention period and its following stool collection period)
  • Stool moisture(During each 3-day intervention period and its following stool collection period)
  • Fecal pH(During each 3-day intervention period and its following stool collection period)
  • Fecal host DNA concentration(During each 3-day intervention period and its following stool collection period)
  • Fecal short-chain fatty acids(During each 3-day intervention period and its following stool collection period)
  • Gut microbiome composition (16S)(During each 3-day intervention period and its following stool collection period)
  • Gut microbiome composition and functions (shotgun sequencing)(During each 3-day intervention period and its following stool collection period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Henrik Munch Roager

Associate Professor

University of Copenhagen

研究点 (1)

Loading locations...

相似试验

Why Calories Are Not the Same - a Gut Explanation? | 临床试验